The Alzheimer Conundrum : : Entanglements of Dementia and Aging / / Margaret Lock.
Due to rapidly aging populations, the number of people worldwide experiencing dementia is increasing, and the projections are grim. Despite billions of dollars invested in medical research, no effective treatment has been discovered for Alzheimer's disease, the most common form of dementia. The...
Saved in:
| Superior document: | Title is part of eBook package: De Gruyter Princeton University Press eBook-Package Backlist 2000-2013 |
|---|---|
| VerfasserIn: | |
| Place / Publishing House: | Princeton, NJ : : Princeton University Press, , [2013] ©2013 |
| Year of Publication: | 2013 |
| Edition: | Course Book |
| Language: | English |
| Online Access: | |
| Physical Description: | 1 online resource (328 p.) :; 12 line illus. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 06286nam a22014895i 4500 | ||
|---|---|---|---|
| 001 | 9781400848461 | ||
| 003 | DE-B1597 | ||
| 005 | 20210830012106.0 | ||
| 006 | m|||||o||d|||||||| | ||
| 007 | cr || |||||||| | ||
| 008 | 210830t20132013nju fo d z eng d | ||
| 020 | |a 9781400848461 | ||
| 024 | 7 | |a 10.1515/9781400848461 |2 doi | |
| 035 | |a (DE-B1597)474190 | ||
| 035 | |a (OCoLC)1004867046 | ||
| 040 | |a DE-B1597 |b eng |c DE-B1597 |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a nju |c US-NJ | ||
| 050 | 4 | |a RC521 | |
| 072 | 7 | |a SOC002000 |2 bisacsh | |
| 082 | 0 | 4 | |a 362.19683 |2 23 |
| 100 | 1 | |a Lock, Margaret, |e author. |4 aut |4 http://id.loc.gov/vocabulary/relators/aut | |
| 245 | 1 | 4 | |a The Alzheimer Conundrum : |b Entanglements of Dementia and Aging / |c Margaret Lock. |
| 250 | |a Course Book | ||
| 264 | 1 | |a Princeton, NJ : |b Princeton University Press, |c [2013] | |
| 264 | 4 | |c ©2013 | |
| 300 | |a 1 online resource (328 p.) : |b 12 line illus. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | 0 | |t Frontmatter -- |t Contents -- |t Acknowledgments -- |t Orientations -- |t Chapter 1. Making And Remaking Alzheimer Disease -- |t Chapter 2. Striving to Standardize Alzheimer Disease -- |t Chapter 3. Paths to Alzheimer Prevention -- |t Chapter 4. Embodied Risk Made Visible -- |t Chapter 5. Alzheimer Genes: Biomarkers of Prediction and Prevention -- |t Chapter 6. Genome- Wide Association Studies: Back to the Future -- |t Chapter 7. Living with Embodied Omens -- |t Chapter 8. Chance Untamed and the Return of Fate -- |t Chapter 9. Transcending Entrenched Tensions -- |t Afterword. Portraits from the Mind -- |t Notes -- |t Index |
| 506 | 0 | |a restricted access |u http://purl.org/coar/access_right/c_16ec |f online access with authorization |2 star | |
| 520 | |a Due to rapidly aging populations, the number of people worldwide experiencing dementia is increasing, and the projections are grim. Despite billions of dollars invested in medical research, no effective treatment has been discovered for Alzheimer's disease, the most common form of dementia. The Alzheimer Conundrum exposes the predicaments embedded in current efforts to slow down or halt Alzheimer's disease through early detection of pre-symptomatic biological changes in healthy individuals.Based on a meticulous account of the history of Alzheimer's disease and extensive in-depth interviews, Margaret Lock highlights the limitations and the dissent associated with biomarker detection. Lock argues that basic research must continue, but should be complemented by a public health approach to prevention that is economically feasible, more humane, and much more effective globally than one exclusively focused on an increasingly harried search for a cure. | ||
| 530 | |a Issued also in print. | ||
| 538 | |a Mode of access: Internet via World Wide Web. | ||
| 546 | |a In English. | ||
| 588 | 0 | |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 30. Aug 2021) | |
| 650 | 0 | |a Alzheimer's disease |x Age factors. | |
| 650 | 0 | |a Alzheimer's disease. | |
| 650 | 0 | |a Brain |x Aging |x Molecular aspects. | |
| 650 | 0 | |a Dementia. | |
| 650 | 0 | |a Electronic books. | |
| 650 | 0 | |a Older people |x Mental health. | |
| 650 | 7 | |a SOCIAL SCIENCE / Anthropology / General. |2 bisacsh | |
| 653 | |a APOE. | ||
| 653 | |a Alois Alzheimer. | ||
| 653 | |a Alzheimer disease. | ||
| 653 | |a Alzheimer enterprise. | ||
| 653 | |a Alzheimer genetics. | ||
| 653 | |a Alzheimer prevention. | ||
| 653 | |a Alzheimer world. | ||
| 653 | |a Alzheimer's disease. | ||
| 653 | |a DNA samples. | ||
| 653 | |a DNA. | ||
| 653 | |a GWAS. | ||
| 653 | |a Huntington disease. | ||
| 653 | |a aging population. | ||
| 653 | |a aging populations. | ||
| 653 | |a aging societies. | ||
| 653 | |a amyloid cascade hypothesis. | ||
| 653 | |a amyloid cascade process. | ||
| 653 | |a behavioral changes. | ||
| 653 | |a biomarkers. | ||
| 653 | |a biosociality. | ||
| 653 | |a breast cancer. | ||
| 653 | |a clinical diagnosis. | ||
| 653 | |a clinical settings. | ||
| 653 | |a control samples. | ||
| 653 | |a dementia. | ||
| 653 | |a diagnosis. | ||
| 653 | |a divination. | ||
| 653 | |a early-onset. | ||
| 653 | |a environmental variables. | ||
| 653 | |a epidemiological research. | ||
| 653 | |a epidemiology. | ||
| 653 | |a epigenetics. | ||
| 653 | |a ethnographic research. | ||
| 653 | |a expert knowledge. | ||
| 653 | |a family practice settings. | ||
| 653 | |a gene function. | ||
| 653 | |a genes. | ||
| 653 | |a genetic testing. | ||
| 653 | |a geneticization. | ||
| 653 | |a genome-wide association studies. | ||
| 653 | |a genomics. | ||
| 653 | |a global economy. | ||
| 653 | |a late-onset. | ||
| 653 | |a localization theory. | ||
| 653 | |a medical publications. | ||
| 653 | |a memory clinics. | ||
| 653 | |a memory loss. | ||
| 653 | |a micro-medical management. | ||
| 653 | |a mild cognitive impairment. | ||
| 653 | |a molecular approach. | ||
| 653 | |a molecular biologists. | ||
| 653 | |a molecularization. | ||
| 653 | |a neuritic amyloid plaques. | ||
| 653 | |a neurofibrillary tangles. | ||
| 653 | |a neuroimaging. | ||
| 653 | |a prevention. | ||
| 653 | |a prodromal. | ||
| 653 | |a public health. | ||
| 653 | |a research. | ||
| 653 | |a throughput technology. | ||
| 773 | 0 | 8 | |i Title is part of eBook package: |d De Gruyter |t Princeton University Press eBook-Package Backlist 2000-2013 |z 9783110442502 |
| 776 | 0 | |c print |z 9780691149783 | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/9781400848461?locatt=mode:legacy |
| 856 | 4 | 0 | |u https://www.degruyter.com/isbn/9781400848461 |
| 856 | 4 | 2 | |3 Cover |u https://www.degruyter.com/cover/covers/9781400848461.jpg |
| 912 | |a 978-3-11-044250-2 Princeton University Press eBook-Package Backlist 2000-2013 |c 2000 |d 2013 | ||
| 912 | |a EBA_BACKALL | ||
| 912 | |a EBA_CL_SN | ||
| 912 | |a EBA_EBACKALL | ||
| 912 | |a EBA_EBKALL | ||
| 912 | |a EBA_ECL_SN | ||
| 912 | |a EBA_EEBKALL | ||
| 912 | |a EBA_ESSHALL | ||
| 912 | |a EBA_PPALL | ||
| 912 | |a EBA_SSHALL | ||
| 912 | |a EBA_STMALL | ||
| 912 | |a GBV-deGruyter-alles | ||
| 912 | |a PDA11SSHE | ||
| 912 | |a PDA12STME | ||
| 912 | |a PDA13ENGE | ||
| 912 | |a PDA17SSHEE | ||
| 912 | |a PDA5EBK | ||